IR-inducible clusterin gene expression: A protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects

Dmitry Klokov, Tracy Criswell, Konstantin S. Leskov, Shinako Araki, Lindsey Mayo, David A. Boothman

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Clusterin (CLU) plays numerous roles in mammalian cells after stress. A review of the recent literature strongly suggests potential roles for CLU proteins in low dose ionizing radiation (IR)-inducible adaptive responses, bystander effects, and delayed death and genomic instability. Its most striking and evident feature is the inducibility of the CLU promoter after low, as well as high, doses of IR. Two major forms of CLU, secreted (sCLU) and nuclear (nCLU), possess opposite functions in cellular responses to IR: sCLU is cytoprotective, whereas nCLU (a byproduct of alternative splicing) is a pro-death factor. Recent studies from our laboratory and others demonstrated that down-regulation of sCLU by specific siRNA increased cytotoxic responses to chemotherapy and IR. sCLU was induced after low non-toxic doses of IR (0.02-0.5 Gy) in human cultured cells and in mice in vivo. The low dose inducibility of this survival protein suggests a possible role for sCLU in radiation adaptive responses, characterized by increased cell radioresistance after exposure to low adapting IR doses. Although it is still unclear whether the adaptive response is beneficial or not to cells, survival of damaged cells after IR may lead to genomic instability in the descendants of surviving cells. Recent studies indicate a link between sCLU accumulation and cancer incidence, as well as aging, supporting involvement of the protein in the development of genomic instability. Secreted after IR, sCLU may also alter intracellular communication due to its ability to bind cell surface receptors, such as the TGF-β receptors (types I and II). This interference with signaling pathways may contribute to IR-induced bystander effects. We hypothesize that activation of the TGF-β signaling pathway, which often occurs after IR exposure, can in turn activate the CLU promoter. TGF-β and IR-inducible de novo synthesized sCLU may then bind the TGF-β receptors and suppress downstream growth arrest signaling. This complicated negative feedback regulation most certainly depends on the cellular microenvironment, but undoubtedly represents a potential link between IR-induced adaptive responses, genomic instability and bystander effects. Further elucidation of clusterin protein functions in IR responses are clearly warranted.

Original languageEnglish (US)
Pages (from-to)97-110
Number of pages14
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume568
Issue number1 SPEC. ISS.
DOIs
StatePublished - Dec 2 2004

Fingerprint

Clusterin
Bystander Effect
Genomic Instability
Ionizing Radiation
Gene Expression
Proteins
Cellular Microenvironment
Aptitude
Alternative Splicing
Cell Surface Receptors
Small Interfering RNA

Keywords

  • Clusterin gene
  • Pro-death factor
  • Protein

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Molecular Biology

Cite this

IR-inducible clusterin gene expression : A protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects. / Klokov, Dmitry; Criswell, Tracy; Leskov, Konstantin S.; Araki, Shinako; Mayo, Lindsey; Boothman, David A.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 568, No. 1 SPEC. ISS., 02.12.2004, p. 97-110.

Research output: Contribution to journalArticle

Klokov, Dmitry ; Criswell, Tracy ; Leskov, Konstantin S. ; Araki, Shinako ; Mayo, Lindsey ; Boothman, David A. / IR-inducible clusterin gene expression : A protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects. In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 2004 ; Vol. 568, No. 1 SPEC. ISS. pp. 97-110.
@article{04ba2355855b4012a8f424860aa65919,
title = "IR-inducible clusterin gene expression: A protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects",
abstract = "Clusterin (CLU) plays numerous roles in mammalian cells after stress. A review of the recent literature strongly suggests potential roles for CLU proteins in low dose ionizing radiation (IR)-inducible adaptive responses, bystander effects, and delayed death and genomic instability. Its most striking and evident feature is the inducibility of the CLU promoter after low, as well as high, doses of IR. Two major forms of CLU, secreted (sCLU) and nuclear (nCLU), possess opposite functions in cellular responses to IR: sCLU is cytoprotective, whereas nCLU (a byproduct of alternative splicing) is a pro-death factor. Recent studies from our laboratory and others demonstrated that down-regulation of sCLU by specific siRNA increased cytotoxic responses to chemotherapy and IR. sCLU was induced after low non-toxic doses of IR (0.02-0.5 Gy) in human cultured cells and in mice in vivo. The low dose inducibility of this survival protein suggests a possible role for sCLU in radiation adaptive responses, characterized by increased cell radioresistance after exposure to low adapting IR doses. Although it is still unclear whether the adaptive response is beneficial or not to cells, survival of damaged cells after IR may lead to genomic instability in the descendants of surviving cells. Recent studies indicate a link between sCLU accumulation and cancer incidence, as well as aging, supporting involvement of the protein in the development of genomic instability. Secreted after IR, sCLU may also alter intracellular communication due to its ability to bind cell surface receptors, such as the TGF-β receptors (types I and II). This interference with signaling pathways may contribute to IR-induced bystander effects. We hypothesize that activation of the TGF-β signaling pathway, which often occurs after IR exposure, can in turn activate the CLU promoter. TGF-β and IR-inducible de novo synthesized sCLU may then bind the TGF-β receptors and suppress downstream growth arrest signaling. This complicated negative feedback regulation most certainly depends on the cellular microenvironment, but undoubtedly represents a potential link between IR-induced adaptive responses, genomic instability and bystander effects. Further elucidation of clusterin protein functions in IR responses are clearly warranted.",
keywords = "Clusterin gene, Pro-death factor, Protein",
author = "Dmitry Klokov and Tracy Criswell and Leskov, {Konstantin S.} and Shinako Araki and Lindsey Mayo and Boothman, {David A.}",
year = "2004",
month = "12",
day = "2",
doi = "10.1016/j.mrfmmm.2004.06.049",
language = "English (US)",
volume = "568",
pages = "97--110",
journal = "Mutation Research",
issn = "0027-5107",
publisher = "Elsevier",
number = "1 SPEC. ISS.",

}

TY - JOUR

T1 - IR-inducible clusterin gene expression

T2 - A protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects

AU - Klokov, Dmitry

AU - Criswell, Tracy

AU - Leskov, Konstantin S.

AU - Araki, Shinako

AU - Mayo, Lindsey

AU - Boothman, David A.

PY - 2004/12/2

Y1 - 2004/12/2

N2 - Clusterin (CLU) plays numerous roles in mammalian cells after stress. A review of the recent literature strongly suggests potential roles for CLU proteins in low dose ionizing radiation (IR)-inducible adaptive responses, bystander effects, and delayed death and genomic instability. Its most striking and evident feature is the inducibility of the CLU promoter after low, as well as high, doses of IR. Two major forms of CLU, secreted (sCLU) and nuclear (nCLU), possess opposite functions in cellular responses to IR: sCLU is cytoprotective, whereas nCLU (a byproduct of alternative splicing) is a pro-death factor. Recent studies from our laboratory and others demonstrated that down-regulation of sCLU by specific siRNA increased cytotoxic responses to chemotherapy and IR. sCLU was induced after low non-toxic doses of IR (0.02-0.5 Gy) in human cultured cells and in mice in vivo. The low dose inducibility of this survival protein suggests a possible role for sCLU in radiation adaptive responses, characterized by increased cell radioresistance after exposure to low adapting IR doses. Although it is still unclear whether the adaptive response is beneficial or not to cells, survival of damaged cells after IR may lead to genomic instability in the descendants of surviving cells. Recent studies indicate a link between sCLU accumulation and cancer incidence, as well as aging, supporting involvement of the protein in the development of genomic instability. Secreted after IR, sCLU may also alter intracellular communication due to its ability to bind cell surface receptors, such as the TGF-β receptors (types I and II). This interference with signaling pathways may contribute to IR-induced bystander effects. We hypothesize that activation of the TGF-β signaling pathway, which often occurs after IR exposure, can in turn activate the CLU promoter. TGF-β and IR-inducible de novo synthesized sCLU may then bind the TGF-β receptors and suppress downstream growth arrest signaling. This complicated negative feedback regulation most certainly depends on the cellular microenvironment, but undoubtedly represents a potential link between IR-induced adaptive responses, genomic instability and bystander effects. Further elucidation of clusterin protein functions in IR responses are clearly warranted.

AB - Clusterin (CLU) plays numerous roles in mammalian cells after stress. A review of the recent literature strongly suggests potential roles for CLU proteins in low dose ionizing radiation (IR)-inducible adaptive responses, bystander effects, and delayed death and genomic instability. Its most striking and evident feature is the inducibility of the CLU promoter after low, as well as high, doses of IR. Two major forms of CLU, secreted (sCLU) and nuclear (nCLU), possess opposite functions in cellular responses to IR: sCLU is cytoprotective, whereas nCLU (a byproduct of alternative splicing) is a pro-death factor. Recent studies from our laboratory and others demonstrated that down-regulation of sCLU by specific siRNA increased cytotoxic responses to chemotherapy and IR. sCLU was induced after low non-toxic doses of IR (0.02-0.5 Gy) in human cultured cells and in mice in vivo. The low dose inducibility of this survival protein suggests a possible role for sCLU in radiation adaptive responses, characterized by increased cell radioresistance after exposure to low adapting IR doses. Although it is still unclear whether the adaptive response is beneficial or not to cells, survival of damaged cells after IR may lead to genomic instability in the descendants of surviving cells. Recent studies indicate a link between sCLU accumulation and cancer incidence, as well as aging, supporting involvement of the protein in the development of genomic instability. Secreted after IR, sCLU may also alter intracellular communication due to its ability to bind cell surface receptors, such as the TGF-β receptors (types I and II). This interference with signaling pathways may contribute to IR-induced bystander effects. We hypothesize that activation of the TGF-β signaling pathway, which often occurs after IR exposure, can in turn activate the CLU promoter. TGF-β and IR-inducible de novo synthesized sCLU may then bind the TGF-β receptors and suppress downstream growth arrest signaling. This complicated negative feedback regulation most certainly depends on the cellular microenvironment, but undoubtedly represents a potential link between IR-induced adaptive responses, genomic instability and bystander effects. Further elucidation of clusterin protein functions in IR responses are clearly warranted.

KW - Clusterin gene

KW - Pro-death factor

KW - Protein

UR - http://www.scopus.com/inward/record.url?scp=7644238657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7644238657&partnerID=8YFLogxK

U2 - 10.1016/j.mrfmmm.2004.06.049

DO - 10.1016/j.mrfmmm.2004.06.049

M3 - Article

C2 - 15530543

AN - SCOPUS:7644238657

VL - 568

SP - 97

EP - 110

JO - Mutation Research

JF - Mutation Research

SN - 0027-5107

IS - 1 SPEC. ISS.

ER -